Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection

被引:155
作者
Hoelscher, Christian [1 ]
机构
[1] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
TYPE-2; DIABETES-MELLITUS; GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; RECEPTOR STIMULATION; INSULIN-RESISTANCE; SYNAPTIC PLASTICITY; AMYLOID-BETA; PLASMA-MEMBRANE; RODENT MODELS; ANIMAL-MODEL;
D O I
10.2165/11635890-000000000-00000
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The current understanding of neurodegenerative processes in sporadic diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) or multiple sclerosis is very limited. Several risk factors have been identified that may shed light on the underlying mechanisms that initiate the neurodegeneration. Type 2 diabetes mellitus has been identified as a risk factor for AD and PD. In AD patients, desensitization of insulin receptors in the brain has been shown, even in non-diabetic patients. Insulin acts as a growth factor in the brain and supports neuronal repair, dendritic sprouting and synaptogenesis, and protection from oxidative stress. Importantly, several drugs have been developed to treat type 2 diabetes that re-sensitize insulin receptors and may be of use to prevent neurodegenerative processes. Glucagon-like peptide-1 (GLP-1) is a hormone that facilitates insulin release under high blood sugar conditions. Interestingly, GLP-1 also has very similar growth factor-like properties to insulin, and has been shown to reduce a range of degenerative processes. In pre-clinical studies, GLP-1 and longer-lasting protease-resistant analogues cross the blood-brain barrier, protect memory formation (AD) or motor activity (PD), protect synapses and synaptic functions, enhance neurogenesis, reduce apoptosis, protect neurons from oxidative stress, and reduce plaque formation and the chronic inflammation response in the brains of mouse models of AD, PD, amyotrophic lateral sclerosis, stroke and other degenerative diseases. GLP-1 signalling does not affect blood sugar levels in non-diabetic people and therapies that affect GLP-1 signalling have a good safety profile as shown by the chronic application of drugs currently on the market (liraglutide, Victoza (R); NovoNordisk, Copenhagen, Denmark, and exendin-4, Byetta (R); Amylin, San Diego, CA, USA). Based on the extensive evidence, several clinical trials are currently underway, testing liraglutide and exendin-4 in AD and PD patients. Therefore, GLP-1 analogues show great promise as a novel treatment for AD or other neurodegenerative conditions.
引用
收藏
页码:871 / 882
页数:12
相关论文
共 97 条
[1]   Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate [J].
Aharoni, Rina ;
Vainshtein, Anya ;
Stock, Ariel ;
Eilam, Raya ;
From, Renana ;
Shinder, Vera ;
Arnon, Ruth .
JOURNAL OF AUTOIMMUNITY, 2011, 37 (03) :228-241
[2]   Immunomodulatory drug treatment in multiple sclerosis [J].
Aharoni, Rina .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (09) :1423-1436
[3]   Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 [J].
Arakawa, Masayuki ;
Mita, Tomoya ;
Azuma, Kosuke ;
Ebato, Chie ;
Goto, Hiromasa ;
Nomiyama, Takashi ;
Fujitani, Yoshio ;
Hirose, Takahisa ;
Kawamori, Ryuzo ;
Watada, Hirotaka .
DIABETES, 2010, 59 (04) :1030-1037
[4]   Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate [J].
Arnon, Ruth ;
Aharoni, Rina .
JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (11) :1443-1449
[5]  
Aviles-Olmos I., 2013, Brain
[6]   Inflammatory mediator and β-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E [J].
Ayasolla, K ;
Khan, M ;
Singh, AK ;
Singh, I .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (03) :325-338
[7]   VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model [J].
Azzouz, M ;
Ralph, GS ;
Storkebaum, E ;
Walmsley, LE ;
Mitrophanous, KA ;
Kingsman, SM ;
Carmeliet, P ;
Mazarakis, ND .
NATURE, 2004, 429 (6990) :413-417
[8]   Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase-dependent mechanism [J].
Benomar, Y ;
Naour, N ;
Aubourg, A ;
Bailleux, V ;
Gertler, A ;
Djiane, J ;
Guerre-Millo, M ;
Taouis, M .
ENDOCRINOLOGY, 2006, 147 (05) :2550-2556
[9]   Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease [J].
Bertilsson, Goran ;
Patrone, Cesare ;
Zachrisson, Olof ;
Andersson, Annica ;
Dannaeus, Karin ;
Heidrich, Jessica ;
Kortesmaa, Jarkko ;
Mercer, Alex ;
Nielsen, Elisabet ;
Roennholm, Harriet ;
Wikstroem, Lilian .
JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (02) :326-338
[10]   Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus [J].
Biessels, GJ ;
De Leeuw, FE ;
Lindeboom, J ;
Barkhof, F ;
Scheltens, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (03) :304-307